Cargando…
Current molecular diagnostics assays for SARS-CoV-2 and emerging variants
Since the SARS-CoV-2 virus triggered the beginning of the COVID-19 pandemic, scientists, government officials, and healthcare professionals around the world recognized the need for accessible, affordable, and accurate testing to predict and contain the spread of COVID-19. In the months that followed...
Autores principales: | Banks, Jonathan M., Capistrano, Kristelle, Thakkar, Pari, Ranade, Hemangi, Soni, Vaidik, Datta, Manali, Naqvi, Afsar R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655725/ http://dx.doi.org/10.1016/bs.mim.2021.10.003 |
Ejemplares similares
-
Host microRNAs exhibit differential propensity to interact with SARS-CoV-2 and variants of concern
por: Capistrano, Kristelle J., et al.
Publicado: (2023) -
Predicting Diagnostic Potential of Cathepsin in Epithelial Ovarian Cancer: A Design Validated by Computational, Biophysical and Electrochemical Data
por: Ranade, Hemangi, et al.
Publicado: (2021) -
Improved air quality and associated mortalities in India under COVID-19 lockdown()
por: Naqvi, Hasan Raja, et al.
Publicado: (2021) -
Detection of SARS-CoV-2 variants by multiple diagnostic assays
por: Feumba, G. Stephanie, et al.
Publicado: (2022) -
SARS-CoV-2 diagnostics: Some reflections on current assays
por: Antonelli, Guido, et al.
Publicado: (2021)